Results 291 to 300 of about 1,923,290 (310)
Some of the next articles are maybe not open access.
The Lancet, 2018
Hepatocellular carcinoma appears frequently in patients with cirrhosis. Surveillance by biannual ultrasound is recommended for such patients because it allows diagnosis at an early stage, when effective therapies are feasible. The best candidates for resection are patients with a solitary tumour and preserved liver function.
Alejandro, Forner +2 more
openaire +2 more sources
Hepatocellular carcinoma appears frequently in patients with cirrhosis. Surveillance by biannual ultrasound is recommended for such patients because it allows diagnosis at an early stage, when effective therapies are feasible. The best candidates for resection are patients with a solitary tumour and preserved liver function.
Alejandro, Forner +2 more
openaire +2 more sources
The Lancet, 1999
Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few exceptions, treatment is largely palliative, and long-term survival is rare. However, the major causes of HCC worldwide are known and preventable.
D F, Schafer, M F, Sorrell
openaire +2 more sources
Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few exceptions, treatment is largely palliative, and long-term survival is rare. However, the major causes of HCC worldwide are known and preventable.
D F, Schafer, M F, Sorrell
openaire +2 more sources
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers.
Cancer metastasis reviews, 2023Yu Wang, B. Deng
semanticscholar +1 more source
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Nature reviews: Gastroenterology & hepatology, 2023J. Llovet +7 more
semanticscholar +1 more source
Hepatocellular Carcinoma: New Developments.
Clinical Liver Disease, 2023Previn Ganesan, L. Kulik
semanticscholar +1 more source
Immunotherapies for hepatocellular carcinoma
Nature Reviews Clinical Oncology, 2021J. Llovet +8 more
semanticscholar +1 more source
Biomarkers for immunotherapy of hepatocellular carcinoma
Nature Reviews Clinical Oncology, 2023Tim F Greten +7 more
semanticscholar +1 more source
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.
Journal of Hepatology, 2018P. Galle +7 more
semanticscholar +1 more source